Lonza | LONN - Sales Revenues


Lonza reported CHF3.58B in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Akzo Nobel EUR 2.59B 200M Jun/2026
Alcon AG USD 2.69B 10M Mar/2026
Almirall EUR 602.71M 55.09M Jun/2026
AstraZeneca USD 15.38B 90M Jun/2026
BASF EUR 17.21B 1.19B Jun/2026
Bayer EUR 10.87B 2.54B Jun/2026
Beiersdorf EUR 2.45B 30M Jun/2026
Covestro EUR 6.73B 3.82B Jun/2026
Demant DKK 6.25B 800M Dec/2025
Fresenius EUR 5.95B 210M Jun/2026
Fresenius Medical Care EUR 4.86B 250M Jun/2026
Geberit CHF 715.4M 67.1M Dec/2025
Genmab DKK 1.16B 259M Jun/2026
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 8.41B 781M Jun/2026
GN Store Nord DKK 3.85B 830M Mar/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Johnson Matthey GBP 1.28B 0 Mar/2026
Merck EUR 5.13B 120M Mar/2026
Novartis USD 14.41B 1.3B Jun/2026
Philips EUR 4.36B 450M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sanofi EUR 11.95B 710M Jun/2026
Sika AG CHF 5.52B 151.5M Dec/2025
Smith & Nephew USD 1.6B 1.58B Jun/2026
Solvay EUR 1.03B 33M Jun/2026
UCB EUR 4.25B 764M Dec/2025